Candel Therapeutics Inc (CADL)

Cost of Revenue

$0.00

Quarterly · Period ending: · USD

CADL logo

CADL Cost of Revenue

Latest reported$0.00
CADL Quarterly Cost of Revenue ($1.62M → $0.00)
High-resolution chart · PNG

CADL cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Candel Therapeutics Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
276,000
0
0
0
178,000
0
3,292,000
2,753,000
0
0
1,795,000
1,621,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.